Relationship Between the Review Time and Various PMDA Consultations in Recent New Drug Approval Cases in Japan

Keiji Nishiyama, Satoshi Toyoshima, Hiroaki Yamada, Hirofumi Suzuki, Naomi Nagai
  • Therapeutic Innovation & Regulatory Science, March 2018, SAGE Publishing
  • DOI: 10.1177/2168479018762795
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: